Hepatocellular Adenoma

Hepatocellular adenoma (also known as hepatic adenoma or hepadenoma) is a rare, benign liver tumor. It most commonly occurs in people with elevated systemic levels of estrogen, classically in women taking estrogen-containing oral contraceptive medication. Hepatic adenoma is usually detected by imaging, typically an ultrasound or CT, as a hyper enhancing liver nodule. Given that several liver tumors appear similarly on these imaging modalities, a multi-phase contrast-enhanced imaging study such as CT or MRI may be used to provide more information.

You may not know you have a hepatic adenoma unless it ruptures. A ruptured hepatic adenoma is serious. It can cause:


  • sudden abdominal pain low blood pressure internal bleeding
  • low blood pressure
  • internal bleeding

Related Conference of Hepatocellular Adenoma

August 05-06, 2021

Global Congress on Pancreas

Zurich, Switzerland
September 27-28, 2021

8th Global Conference on Mass Spectrometry

Tokyo, Japan
September 28-29, 2021

2 nd World Congress on Oil and Gas Engineering

Auckland, Newzealand
October 20-21, 2021

9th International Conference on Green Energy and Recycling

Zurich, Switzerland
November 23-24, 2021

World Conference on Digestive and metabolic diseases

Hanoi, Vietnam
December 13-13, 2021

International Conference on Hepatitis

London, UK
April 04-05, 2022

17th Euro-Global Gastroenterology Conference

Rome, Italy
May 25-26, 2022

17th European Gastroenterology & Therapeutics Congress

Zurich, Switzerland
June 13-14, 2022

28th World Conference on Gastroenterology & Hepatology

Amsterdam, Netherlands

Hepatocellular Adenoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in